Spark Therapeutics (United States)
organizationcompany in Philadelphia, United States
Spark Therapeutics, Inc. was a developer of gene therapy treatments, which treat debilitating genetic diseases. It was founded in 2013 and has been a subsidiary of Hoffmann-La Roche since 2020.